Britain's medicines regulator said on Friday it had extended approval of the COVID-19 vaccine developed by Pfizer (PFE.N) and BioNTech (22UAy.DE) so it can be used on 12- to 15-year-olds.
Published 4 years ago on Jun 5th 2021, 6:33 am
By Web Desk
"We have carefully reviewed clinical trial data in children aged 12 to 15 years and have concluded that the Pfizer/BioNTech COVID-19 vaccine is safe and effective in this age group and that the benefits of this vaccine outweigh any risk," June Raine, chief executive of the Medicines and Healthcare products Regulatory Agency, said.
She added that it would be up to the Joint Committee on Vaccination and Immunisation to decide whether this age group would come under the vaccine deployment programme.
Courtesy: Reuters
OpenAI hires former head of the Facebook app
- 42 منٹ قبل
Apple has a new ‘Viral’ playlist on Apple Music and Shazam
- 43 منٹ قبل
India fired missiles at Nur Khan, Murid, Shorkot airbases but all PAF assets safe: DG ISPR
- ایک گھنٹہ قبل
Wikipedia fights the UK’s ‘flawed’ and ‘burdensome’ online safety rules
- 43 منٹ قبل
Ukraine arrests ex-soldiers accused of spying for Hungary
- 7 گھنٹے قبل
Pakistan military’s retaliation to Indian aggression has begun: State media
- 13 منٹ قبل
The next Lord of the Rings movie debuts in December 2027
- 43 منٹ قبل
I put four robot lawnmowers through a brutal backyard battle — and only one person got injured
- 42 منٹ قبل
IMF approves $1bn loan for Pakistan
- 8 گھنٹے قبل
NEPRA announces Rs1.83 per unit cut in electricity prices
- 8 گھنٹے قبل
Six ballistic missiles fired by India ‘targeting its own population’, says DG ISPR
- 3 گھنٹے قبل
Punjab launches province-wide civil defense training initiative
- 7 گھنٹے قبل
You May Like
Trending
